On January
10, 2020, the U.S. Government Accountability Office (GAO) released a report
(the Report) analyzing HRSA’s oversight of 340B eligibility requirements for
nongovernmental hospitals. The Report concludes
Last week, Apexus published a tool which states for the first time HRSA’s policy that all non-FQHC federal grantees are required to register each of
In a Federal Register notice issued yesterday, CMS announced that it intends to survey hospitals on their acquisition costs for covered outpatient drugs purchased under the 340B
The Centers for Disease Control and Prevention (CDC)/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHAC) has scheduled a public meeting
This week, RWC-340B member Cempa Community Care was awarded the Times Free Press Champions of Health Care – Community Outreach Award. Cempa is located in
On July 9, 2019, HRSA issued an Information Collection Request (ICR) announcing that it would be embarking on a two year study entitled, “Assessing Care
A study from the National Institute of Allergy and Infectious Diseases (NIAID) and National Institute of Mental Health (both within the National Institutes of Health)
On July 5, 2019, the U.S. Department of Health and Human Services, Office of Inspector General (OIG) released a report which found that the Medicare
On July 8, 2019, RWC-340B submitted a comment letter in response to the HRSA Information Collection Request (ICR) published in the Federal Register on May
On June 18, 2019, HRSA issued an information collection request (ICR) regarding the guidelines for manufacturer audits of 340B covered entities and the OPA informal
